ArticleHepatology (Baltimore, Md.)2025

Back to phosphodiesterase inhibitors for liver disease: Are we ready for clinical trials?

Leila Gobejishvili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.